# US 2025/0145651 A1 · Method of preparation of 1-(n-(quinolin-2-yl)-(phenylamino)-1-deoxy-beta-d-glucopyranuronic acid derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0145651 A1
- Document ID: US20250145651A1
- Status: Published application
- Kind: A1
- Application number: 18/722,995
- Filed: 2022-12-20
- Published: 2025-05-08
- Earliest claimed: 2021-12-21
- Assignees: Abivax
- Applicants: Abivax
- Inventors: Sébastien ROSE; Guillaume MAGUEUR; Jérôme DENIS
- Web page: https://patentgrep.com/patent/US20250145651A1

## CPC

- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- C07H 17/02: Heterocyclic radicals containing only nitrogen as ring hetero atoms
- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H 1/06: Separation; Purification
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

A process of purification of a crude compound of formula (I) wherein it includes an isolation step of the crude compound of formula (I) including: (i) a solubilization step of the crude compound of formula (I) with methanol followed by a precipitation step with water, and (ii) a drying step under a temperature inferior or equal to 30° C. Herein is further provided a manufacturing process for preparing a compound of formula (I).

## Claims

### Claim 1

A process of purification of a crude compound of formula (I) wherein
each R independently represents hydrogen, halogen, —CN, hydroxyl, (C1-C3)fluoroalkyl, (C1-C3)fluoroalkoxy, (C3-C6)cycloalkyl, —NO2, —NR1R2, (C1-C4)alkoxy, phenoxy, —NR1—SO2—NR1R2, —NR1—SO2—R1, —NR1—C(═O)—R1, —NR1—C(═O)—NR1R2, —SO2-NR1 R2, —SO3H, —O—SO2—OR3, —O—P(═O)—(OR3)(OR4), —O—CH2—COOR3, (C1-C3)alkyl, said alkyl being optionally mono- or di-substituted by a hydroxyl group, a group of formula (IIa):
or a group of formula (IIIa)
each of R1 and R2 is independently hydrogen or (C1-C3)alkyl;
each of R3 and R4 is independently hydrogen, Li+, Na+, K+, N+(Ra)4 or benzyl;
each R′ is independently hydrogen, (C1-C3)alkyl, hydroxyl, halogen, —NO2, —NR1R2, morpholinyl, morpholino, N-methylpiperazinyl, (C1-C3)fluoroalkyl, (C1-C4)alkoxy, —O—P(═O)—(OR3)(OR4), —CN,
a group of formula (IIa):
or a group of formula (IIIa):
A is a covalent bond, oxygen, or NH;
B is a covalent bond or NH;
m is 1, 2, 3, 4 or 5;
p is 1, 2 or 3; each of Ra and Rb is independently hydrogen, (C1-C5)alkyl, or (C3-C6)cycloalkyl, or
Ra and Rb form together with the nitrogen atom to which they are attached a saturated 5- or 6-membered heterocycle, said heterocycle being optionally substituted by one or more Ra, provided that when R′ is a group (IIa) or (IIIa), n′ may be 2 or 3 only if other R′ groups are different from said group (IIa) or (IIIa); and
n is 1, 2 or 3;
n′ is 1, 2 or 3;
wherein it comprises an isolation step of said crude compound of formula (I) including: a solubilization step of said crude compound of formula (I) with methanol followed by a precipitation step with water, and
a drying step under a temperature inferior or equal to 30° C.

### Claim 2 (depends on 1)

The process of purification of a crude compound of formula (I) according to claim 1, wherein
each R independently represent a hydrogen atom, a halogen atom or a group chosen among a —CN group, a hydroxyl group, a —COOR1 group, a (C1-C3)fluoroalkyl group, a (C1-C3)fluoroalkoxy group, a —NO2 group, a —NR1R2 group, a (C1-C4)alkoxy group, a phenoxy group and a (C1-C3)alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group,
R1 and R2 are independently a hydrogen atom or a (C1-C3)alkyl group,
n is 1, 2 or 3,
n′ is 1 or 2, and
each R′ independently represents a hydrogen atom or a group chosen among a (C1-C3)alkyl group, a halogen atom, a hydroxyl group, a —COOR1 group, a —NO2 group, a —NR1R2 group, a morpholinyl or a morpholino group, a N-methylpiperazinyl group, a (C1-C3)fluoroalkyl group, a (C1-C4)alkoxy group and a —CN group.

### Claim 3 (depends on 1)

The process of purification of a crude compound of formula (I) according to claim 1, wherein
each R independently represent a hydrogen atom, a halogen atom or a group chosen among a (C1-C3)fluoroalkyl group, a (C1-C3)fluoroalkoxy group, a —NR1R2 group, a (C1-C4)alkoxy group, a phenoxy group and a (C1-C3)alkyl group, said alkyl being optionally mono-substituted by a hydroxyl group,
R1 and R2 are independently a (C1-C3)alkyl group,
n is 1, 2 or 3,
n′ is 1 or 2, and
each R′ independently represents a hydrogen atom or a group chosen among a (C1-C3)alkyl group, a halogen atom, a —NR1R2 group, a (C1-C3)fluoroalkyl group and a (C1-C4)alkoxy group.

### Claim 4 (depends on 1)

The process of purification of a crude compound of formula (I) according to claim 1, wherein the compound of formula (I) is

### Claim 5 (depends on 1)

The process of purification of a crude compound of formula (I) according to claim 1, wherein it is followed by a purification on silica gel chromatography column, optionally preceded by a silica gel pre-treatment.

### Claim 6 (depends on 1)

The process of purification according to claim 1, wherein it is preceded by a deprotection step of a compound of formula (IV)
wherein R, R′, n and n′ are as defined in claim 1 and each R″ represents a (C1-C4)alkyl group, for obtaining said compound of formula (I) with lithium hydroxide, potassium hydroxide or sodium hydroxide, in presence of a solvent selected from aromatic hydrocarbons; ethers at room temperature.

### Claim 7 (depends on 1)

The process of purification according to claim 1, wherein said compound of formula (IV) is compound (4)

### Claim 8 (depends on 1)

The process of purification according to claim 1, wherein it is preceded by a deprotection step of a compound of formula (IV)
wherein R, R′, n and n′ are as defined in claim 1 and each R″ represents a (C1-C4)alkyl group, for obtaining said compound of formula (I) with lithium hydroxide, potassium hydroxide or sodium hydroxide, in presence of a solvent selected from aromatic hydrocarbons; ethers at room temperature
wherein the deprotection step is preceded by a step of reaction of a compound of formula (II)
with a compound of formula (III)
for obtaining a compound of formula (IV)
wherein R, R′, n and n′ are as defined in claim 1 and each R″ represents a (C1-C4)alkyl group, in particular a methyl group, in the presence of CdCO3, in a solvent selected from aromatic solvents, and with a fractional introduction of the compound of formula (III) in solution.

### Claim 9 (depends on 8)

The process according to claim 8, wherein the compound of formula (II) is compound (2)
and the compound of formula (III) is compound (3)

### Claim 10 (depends on 9)

The process of purification according to claim 9, wherein the fractional introduction of the compound of formula (III) in solution comprises 2 independent additions of the compound of formula (III) in solution, with a first introduction being performed with a molar ratio of compound of compound of formula (III) with respect to the compound of formula (II), ranging from 0.6 to 1, and a second introduction being performed with a molar ratio of compound of formula (III) with respect to the compound of formula (II), ranging from 0.6 to 1, with a total molar ratio with respect to compound of formula (II) ranging from 1.2 to 2.

### Claim 11 (depends on 1)

A manufacturing process for preparing a compound of formula (I) as defined in claim 1, wherein it comprises a step 1, wherein a compound of formula (II)
is reacted with a compound of formula (III)
for obtaining a compound of formula (IV)
wherein R, R′, n and n′ are as defined in claim 1 and each R″ represents a (C1-C4)alkyl group, in the presence of CdCO3, in a solvent selected from aromatic solvents, and with a fractional introduction of the compound of formula (III) in solution,
followed by
a step 2, wherein the compound of formula (IV) is deprotected for obtaining the compound of formula (I) with lithium hydroxide, potassium hydroxide or sodium hydroxide, in absence of hydrogen peroxide and in presence of a solvent selected from aromatic hydrocarbons; ethers, at room temperature.

### Claim 12 (depends on 1)

The process for preparing a compound of formula (I) as defined in claim 1, further comprising the step of preparing a pharmaceutical composition containing such compound of formula (I), with pharmaceutically acceptable excipients.
